Cellestial Health

Cellestial Health is dedicated to advancing biotechnology research, with a focus on protecting brain networks to halt the progression of brain diseases. Cellestial Health develops innovative small molecule therapeutics designed to safeguard networks of brain cells, specifically astrocytes, which are crucial in preventing the advancement of Parkinson's and other neurological disorders.

Located in Cambridge, GB, Cellestial Health is committed to pioneering solutions that address previously overlooked aspects of brain health. Through rigorous research and development, Cellestial Health aims to provide safe and effective treatments that improve patient outcomes and enhance the quality of life for individuals affected by debilitating brain conditions. The company’s work represents a significant step forward in neurological therapeutics, offering hope for more effective management of complex brain disorders.

Cellestial Health's approach involves creating targeted therapies that can protect vulnerable brain cells and networks, thereby slowing or stopping the progression of diseases like Parkinson's. With a focus on astrocytes, Cellestial Health is developing novel strategies to combat the underlying mechanisms of neurological decline. We invite the manager of Cellestial Health to create a customized and exclusive company showcase and product listing on our platform to further highlight these groundbreaking advancements.